Literature DB >> 8083993

The human cytomegalovirus origin of DNA replication (oriLyt) is the critical cis-acting sequence regulating replication-dependent late induction of the viral 1.2-kilobase RNA promoter.

E J Wade1, D H Spector.   

Abstract

Plasmid constructs containing the 1.2-kb RNA promoter from the long terminal repeat region of human cytomegalovirus (HCMV) display the early-phase regulation of this promoter but lack the characteristic late induction (E. J. Wade, K. M. Klucher, and D. H. Spector, J. Virol. 66:2407-2417, 1992). To determine if the HCMV origin of replication (oriLyt) was necessary and sufficient for the late induction of the 1.2-kb RNA promoter, we cloned a 9.6-kbp segment of the origin of replication onto the p456 OCAT plasmid containing the 1.2-kb RNA promoter. This plasmid was designated ori456 OCAT. A control construct, which contains all of the same sequences as the ori456 OCAT construct except that a 2.4-kbp segment derived from HCMV EcoRI segment U is inverted in orientation to disrupt the origin function, was designated inv456 OCAT. After electroporation into human fibroblast cells and infection with HCMV 24 h later, ori456 OCAT replicated and showed the same early and late transcription pattern as the authentic viral 1.2-kb RNA. Under similar conditions, the inv456 OCAT neither replicated nor showed late induction. Experiments using plasmids synthesized in bacteria lacking methylation activity demonstrated that the late induction was not dependent on the change in methylation state of the plasmids. Ganciclovir, an inhibitor of the HCMV DNA polymerase, was used to demonstrate the replication dependence of the expression of the virally encoded 1.2-kb RNA, while the nearby early 2.7-kb RNA was unaffected. Ganciclovir also inhibited the late induction of the chloramphenicol acetyltransferase gene from ori456 OCAT, while expression from inv456 OCAT increased. Site-specific mutations in two previously identified important regulatory elements of the 1.2-kb RNA promoter, the AP1-binding site and the CATA site, indicated that these sites continue to contribute to promoter activity at late times but that the replication-dependent late induction acts independently of these sites. Possible mechanisms underlying the late induction are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083993      PMCID: PMC237077     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Diseases produced by cytomegaloviruses.

Authors:  G A Nankervis; M L Kumar
Journal:  Med Clin North Am       Date:  1978-09       Impact factor: 5.456

2.  Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169.

Authors:  S H McDonough; S I Staprans; D H Spector
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection.

Authors:  M W Wathen; D R Thomsen; M F Stinski
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

4.  Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169.

Authors:  S H McDonough; D H Spector
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

5.  Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs.

Authors:  J M Demarchi
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

6.  Organization and expression of the immediate early genes of human cytomegalovirus.

Authors:  M F Stinski; D R Thomsen; R M Stenberg; L C Goldstein
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

7.  Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.

Authors:  M W Wathen; M F Stinski
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

8.  Predominant immediate-early transcripts of human cytomegalovirus AD 169.

Authors:  G Jahn; E Knust; H Schmolla; T Sarre; J A Nelson; J K McDougall; B Fleckenstein
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

9.  Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169).

Authors:  J C Tamashiro; L J Hock; D H Spector
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  10 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection.

Authors:  S M Rodems; C L Clark; D H Spector
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences.

Authors:  V Koval; F M Jault; P G Pal; T N Moreno; C Aiken; D Trono; S A Spector; D H Spector
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter.

Authors:  Shuang Tang; Koji Yamanegi; Zhi-Ming Zheng
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells.

Authors:  T N Moreno; E A Fortunato; K Hsia; S A Spector; D H Spector
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.

Authors:  Rebecca L Sanders; Charles L Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

7.  Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression.

Authors:  Travis J Chapa; Yi-Cheih Perng; Anthony R French; Dong Yu
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

8.  Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo.

Authors:  Hermine Mohr; Christian A Mohr; Marlon R Schneider; Laura Scrivano; Barbara Adler; Simone Kraner-Schreiber; Angelika Schnieke; Maik Dahlhoff; Eckhard Wolf; Ulrich H Koszinowski; Zsolt Ruzsics
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

9.  Viral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter.

Authors:  Xiaohong Wang; Haibin Liu; Hui Ge; Masahiko Ajiro; Nishi R Sharma; Craig Meyers; Pavel Morozov; Thomas Tuschl; Amar Klar; Donald Court; Zhi-Ming Zheng
Journal:  mBio       Date:  2017-05-30       Impact factor: 7.867

Review 10.  Herpesvirus Late Gene Expression: A Viral-Specific Pre-initiation Complex Is Key.

Authors:  Henri Gruffat; Roberta Marchione; Evelyne Manet
Journal:  Front Microbiol       Date:  2016-06-06       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.